MedTrace Logo

Performance and Safety Evaluation of an Intradermal Delivery Device

NCT01359111 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2012-05-18

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate whether an investigational vaccine delivery device (the ID adapter) can safely and precisely inject liquid into the intradermal layer of the skin.

Conditions

  • Injections, Intradermal

Interventions

DEVICE

PATH ID Adapter

Intradermal delivery device which fits on the end of a syringe to limit the depth and angle of needle penetration into the skin.

Sponsors & Collaborators

  • PATH

    lead OTHER

Principal Investigators

  • Leslie Klaff, MD, PhD · Rainier Clinical Research Center

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2011-05-31
Completion
2011-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01359111 on ClinicalTrials.gov